The Beauty Health Company

Adial Pharmaceuticals, Inc

Haoxi Health Technology Limited Class A

Psyence Biomedical Ltd. Common Shares

Inhibikase Therapeutics, Inc.

Palisade Bio, Inc.

Medical Properties Trust, Inc.

Cue Biopharma, Inc.

Standard BioTools Inc.

Dilution score: 23/100 (LOW), 24.0 months cash

Short interest: 25.0% of float, squeeze risk: HIGH

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line

Evaluation of Molecular Hydrogen Supplementation to Enhance the Efficacy of Weight Loss Retreat in Overweight and Obese 

6 PubMed publications found for The Beauty Health Company

Effect of Protease-Treated Royal Jelly Extract on Facial Wrinkles: A Placebo-Controlled, Double-Blind, Parallel-Group Study.

The efficacy of adjunctive Garcinia mangostana Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trial.

Soy lysolecithin prevents hypertension and cognitive impairment induced in mice by high salt intake by inhibiting intestinal inflammation.

Guidelines of care for the management of acne vulgaris.

Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.

Dilution score: 30/100 (MEDIUM), 999.0 months cash

Short interest: 25.43% of float, squeeze risk: HIGH

SW convergence: 50/100 (Neutral), 1 bullish / 0 bearish signals

Dilution score: 29/100 (MEDIUM), 999.0 months cash

Short interest: 24.08% of float, squeeze risk: HIGH

SW convergence: 50/100 (Neutral), 2 bullish / 1 bearish signals

Short interest: 24.43% of float, squeeze risk: HIGH

Short interest: 24.78% of float, squeeze risk: HIGH

<article class="bts-verified-summary" data-ticker="SKIN">
<p>The Beauty Health Company Class A Common Stock (SKIN) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>SKIN has 7 Form 4 insider filings recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0001818093 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22SKIN%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>

The Beauty Health Company Class A Common Stock

SEC EDGAR — 0001818093

The Beauty Health Company Class A Common Stock (SKIN) — BioTechSigns Verified Summary

The Beauty Health Company Class A Common Stock (SKIN) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

SKIN has 7 Form 4 insider filings recorded at the SEC in the past 30 days[1].

Sources:
[1] SEC EDGAR, 0001818093. Source last updated 2026-04-11, retrieved 2026-04-11.
    https://efts.sec.gov/LATEST/search-index?q=%22SKIN%22&forms=4&dateRange=custom&startdt=2026-03-12&enddt=2026-04-11